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Background: Benign vocal fold lesions, including cysts, nodules, polyps, and Reinke’s edema, are common causes
of hoarseness and subsequent voice disorders. Given the prevalence of these lesions, disease etiology and
pathophysiology remain unclear and their microbiota has not been studied to date secondary to the paucity of
available biopsies for investigation. We sought to characterize and compare the bacterial communities in biopsies
of cysts, nodules, polyps, and Reinke’s edema collected from patients in Germany and Wisconsin. These samples
were then compared to the communities found in healthy saliva and throat samples from the Human Microbiome
Project (HMP).
Results: 454 pyrosequencing of the V3–V5 regions of the 16S rRNA gene revealed five phyla that explained most of
the bacterial diversity, including Firmicutes (73.8%), Proteobacteria (12.7%), Bacteroidetes (9.2%), Actinobacteria (2.1%),
and Fusobacteria (1.9%). Every lesion sample, regardless of diagnosis, had operational taxonomic units (OTUs)
identified as Streptococcus, with a mean abundance of 68.7%. Most of the lesions, 31 out of 44, were
indistinguishable in a principal coordinates analysis (PCoA) due to dominance by OTUs phylogenetically similar to
Streptococcus pseudopneumoniae. Thirteen lesions not dominated by S. pseudopneumoniae were more similar to
HMP throat and saliva samples, though 12 of them contained Pseudomonas, which was not present in any of the
HMP samples. Community structure and abundance could not be correlated with lesion diagnosis or any other
documented patient factor, including age, sex, or country of origin.
Conclusions: Dominance by S. pseudopneumoniae could be a factor in disease etiology, as could the presence of
Pseudomonas in some samples. Likewise, decreased diversity, as compared to healthy saliva and throat samples,
may be associated with disease, similar to disease models in other mucosal sites.
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At any one time, an estimated 20.7 million people in the
US report problems with their voice, while 93.8 million re-
port having problems during their lifetime [1]. Additionally,
an estimated 22.6 million of the general population reports
missing one or more days of work annually because of
voice problems [1]. Voice problems are also associated with
negative effects on quality of life including impaired com-
munication, social isolation, and decreased occupational
productivity [2-4]. Vocal folds play a key role in voice pro-
duction and protection of the lungs, vibrating to produce
sound and closing to protect the lungs against food and li-
quid aspiration during swallowing. Tissue of the vocal folds* Correspondence: THIBEAUL@surgery.wisc.edu
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unless otherwise stated.is unique and complex, composed of an epithelial layer
made up of non-keratinized stratified squamous epithelium
undergoing constant regeneration, which is bound to a
three-layered lamina propria via basement membrane zone
anchoring fibers. Vocal folds are also immunologically ac-
tive serving both as a physical barrier and as a site that may
detect early shifts in microbial presence [5].
While voice problems are associated with many causes,
benign vocal fold lesions are one of the most frequent
medical diagnoses [6]. Benign vocal fold lesions are gener-
ally classified into two broad categories: non-neoplastic
lesions and neoplastic lesions. Non-neoplastic vocal fold
lesions make up the majority of benign lesions and include
cysts, nodules, polyps, Reinke’s edema, granulomas, ecta-
sias, sulcus vocalis, and scar. Benign vocal fold lesions are
typically distinguished by their phenotype, but there isal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Demographic and characteristics of participants




7 5 18 14
Mean age (range) 57 (37–73) 31 (23–38) 44 (24–77) 52 (27–74)
Female/male 6/1 5/0 8/10 14/0
Wisconsin/German 6/1 0/5 6/12 2/12
The table includes information only for samples that resulted in more than
500 sequences and were included in further analyses.
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diseases [7]. Mechanical, chemical, and thermal trauma;
overuse and misuse; or combinations of these factors are
thought to contribute to lesion development via remodel-
ing of the lamina propria. Studies investigating histological
differences and gene expression profiles have demon-
strated differential stages of wound maturation and disor-
dered wound healing [8-10]. While inflammation has
historically been associated with polyps, Kotby et al. sug-
gests that polyps and Reinke’s edema may represent a con-
tinuum of vocal fold injury [11]. Many comorbidities have
been associated with vocal fold lesions, including smoking,
laryngopharyngeal reflux, infection, and allergies [12-14].
To date, microbial contributions to the etiology of vocal
fold lesions have focused mostly on microbes stereotypic-
ally considered pathogens, such as human papillomavirus
and Mycobacterium tuberculosis [15-17]. However, there
remains a lack of data in the literature regarding microbial
community membership for normal and diseased larynx
[18], secondary to a paucity of available tissue for study.
The only study published to date on laryngeal bacterial
communities suggested that laryngeal squamous cell car-
cinoma (LSCC) could be associated with shifts in bacterial
communities in the larynx [19]. Changes in the abundance
of 15 genera were associated with carcinoma versus control
patients with vocal fold polyps. They postulated that in-
creases in Fusobacterium and Prevotella might be involved
in initiating biofilm formation and that it could contribute
to disease progression. Similar work in other mucosal sites
also suggests that changes in bacterial community member-
ship and abundance, despite the absence of classically
defined pathogens, may be associated with disease. Asth-
matics have been found to have altered microbial commu-
nities in their lungs [20]. While the community members
responsible for this change varied between patients, a shift
towards Gram negative-dominated communities was asso-
ciated with elevated lipopolysaccharide levels. The authors
postulated that this may be associated with increased air-
way cell stimulation contributing to disease. Likewise,
Wang et al. found that the abundance of particular oper-
ational taxonomic units (OTUs) were shifted in feces from
patients with colorectal cancer, particularly a reduction in
butyrate-producing bacteria from the family Lachnospiraceae
[21]. They surmised that an increase in potential pathogens
coupled with a decrease in butyrate-producing bacteria
could play a role in tumor formation or contribute to colo-
rectal cancer formation.
Shifts in bacterial communities have been associated
with diseases of mucosal surfaces, and we postulated
that similar changes might be found in benign vocal fold
lesions. In this investigation we characterized and com-
pared the bacterial communities of benign vocal fold
lesions, including biopsies of cysts, nodules, polyps, and
Reinke’s edema. We hypothesized that distinct lesiontypes would be represented by distinct bacterial communi-
ties. This was achieved with 454 pyrosequencing of the
V3-V5 region of the 16S rRNA gene using lesion biopsies
in patients from the state of Wisconsin, USA, and Germany.
Results
Clinical diagnoses and patient characteristics
Forty-nine patients diagnosed with benign vocal fold le-
sions were enrolled in this study. Forty-four lesions in
total were collected and yielded sufficient sequences, in-
cluding 7 cysts, 5 nodules, 18 polyps, and 14 Reinke’s
edema (Table 1). Characteristics of these patients are de-
tailed in Table 1, including mean age, gender, and coun-
try of origin. Five of the 49 initial samples yielded less
than 500 sequences; these samples were eliminated from
further analyses.
Bacterial communities associated with benign vocal fold
lesions
Three 454 GS Junior runs resulted in a total of 248,579
high-quality sequences with a mean length of 471 bp
after quality filtering and removal of primers and adapter
sequences. A total of 44 samples were successfully pyro-
sequenced and yielded over 500 sequences. Samples had
a mean of 5,650 sequences (range 892–23,996). The low-
est Good’s coverage was 0.979 suggesting that communi-
ties were well sampled. No significant differences were
detected between the lesion types by Chao, inverse
Simpson, or Shannon diversity indexes (Table 2).
After removing rare sequences, those present at less
than 0.1% abundance, 334 OTUs were present at 97%
similarity across all samples, representing 5 bacterial
phyla, including, in order of mean abundance, Firmicutes
(73.8%), Proteobacteria (12.7%), Bacteroidetes (9.2%), Acti-
nobacteria (2.1%), and Fusobacteria (1.9%). Sequences
identified as Spirochaetes, Cyanobacteria, Verrucomicro-
bia, Deinococcus-Thermus, Tenericutes, and unclassified
were also present, but inconsistently and at low abundance
(mean less than 0.2%). Individual samples had a mean of
31.6 OTUs, and only ten classes of bacteria explained most
of the diversity found, including Actinobacteria, Bacilli,
Bacteroidia, Clostridia, Flavobacteria, Fusobacteria, Nega-
tivicutes, and Alpha-, Beta-, and Gamma-proteobacteria
Table 2 Mean sequence richness, evenness, and diversity
in lesion samples
Cysts Nodules Polyps Reinke’s
edema
Chao 105.2 ± 25.7 191.0 ± 97.0 112.5 ± 17.4 111.3 ± 15.5
1/Simpson 7.4 ± 2.9 6.1 ± 2.8 4.0 ± 1.3 4.1 ± 1.5
Shannon 1.9 ± 0.5 1.8 ± 0.6 1.3 ± 0.3 1.3 ± 0.3
Good’s
coverage
0.991 ± 0.002 0.996 ± 0.001 0.994 ± 0.001 0.991 ± 0.001
Mean Good’s coverage, Chao, inverse Simpson, and Shannon are reported for
each of the four lesion types, along with standard error. Values for Chao,
Inverse Simpson, and Shannon were not significantly different.
Figure 2 Comparison of bacterial community structure in
benign vocal fold lesions. PCoA based on Theta Yue Clayton
distances illustrating the clustering of most lesion samples,
regardless of lesion diagnosis. Lesion samples are shown as circles,
cysts as orange circles, nodules as yellow circles, polyps as red
circles, and Reinke’s edema as blue circles.
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belonged to the genus Streptococcus. This genus was the
most common and abundant, found in every lesion sam-
ple. An average of 68.7% of all sequences were identified
as Streptococcus (cyst, 60.3%; nodule, 58.1%; polyp, 71.5%;
and Reinke’s edema, 72.9%). Many samples, 31 out of
44, were dominated (at least 50% of total sequences) by
OTUs identified as Streptococcus. Sequences identified
as Helicobacter were present in five samples, one from
Wisconsin, and four from Germany, between 0.03%–1%
relative abundance.
Bacterial community comparison of individual samples
supported the above observations. Communities did not
cluster in the principal coordinates analysis (PCoA) plot
based on lesion type (Figure 2), gender, country of ori-
gin, or age (data not shown), nor any other documented
clinical information. Dominance by Streptococcus isFigure 1 Taxonomic composition in benign vocal fold lesions.
Mean relative abundance of the ten most common and abundant
bacterial classes in cysts, nodules, polyps, and Reinke’s edema. Error
bars represent standard error.evident in Figure 2, where the 31 samples dominated by
Streptococcus all cluster together.
Comparison of healthy HMP samples to lesion
communities
Due to the unethical nature of taking biopsies from healthy
human vocal folds, for further analyses we included 15 ran-
domly selected saliva and throat samples from the Human
Microbiome Project (HMP) as proxies for healthy vocal
fold bacterial communities. Saliva was the most diverse
sample type and was significantly different from all other
samples by both inverse Simpson and Shannon (p < 0.0001)
(Table 3). Throat samples were intermediary, and the differ-
ences in diversity compared to lesion samples were not al-
ways statistically supported.
Tight clustering of lesion samples was not altered in
the PCoA plot with the inclusion of the HMP samples
(Figure 3). However, some lesions had communities
more similar to saliva and throat samples than to other
lesions. OTUs identified as Pseudomonas were present
in 12 of the 13 lesions that did not cluster based on
dominance by Streptococcus, though Pseudomonas was
found in only one throat sample.
The abundance of Streptococcus in lesion samples
At 97% sequence identity, one OTU identified as
Streptococcus was present in every lesion sample at a
mean abundance of 66.21% (range 0.76%–99.76%, 5.01
SE). The sequence selected by mothur to represent this
OTU was identified as S. pseudopneumoniae. However,
16S sequences in the mitis group, of which S. pseudop-
neumoniae is a member, often have greater than 99% se-
quence identity [22,23]. We used the 100 most abundant
Table 3 Mean sequence richness, evenness, and diversity in lesion and HMP samples
Cysts Nodules Polyps Reinke’s edema Saliva Throat
Chao 96.9 ± 23.4b 121.7 ± 43.5 98.1 ± 15.6c 90.2 ± 11.6a 190.1 ± 12.2abc 140.6 ± 11.5
1/Simpson 7.4 ± 2.9 6.0 ± 2.8 4.0 ± 1.3e 4.1 ± 1.5d 17.7 ± 1.6* 11.0 ± 1.4de
Shannon 1.9 ± 0.5 1.8 ± 0.6 1.3 ± 0.3g 1.3 ± 0.3f 3.4 ± 0.1** 2.8 ± 0.1fg
Good’s coverage 0.991 ± 0.002 0.997 ± 0.001 0.994 ± 0.001 0.993 ± 0.001 0.988 ± 0.001 0.992 ± 0.001
Mean Good’s coverage, Chao, inverse Simpson, and Shannon are reported for each of the four lesion types, and saliva and throat samples from the HMP, along
with standard error.
*Saliva was significantly different from all other groups for inverse Simpson (p < 0.0001).
**Saliva was significantly different from all lesion samples for Shannon, but not throat (p < 0.0001).
a–gPairwise comparisons that were significantly different (p < 0.0001).
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plore the diversity and phylogenetic relationship of this
genus present in our samples and the included HMP
samples (Figure 4). Forty of the top 100 Streptococcus
OTUs claded with S. pneumoniae and S. pseudopneumo-
niae, labeled as clade I, which differ by only one base
pair in the region sequenced. Thirty-six of the 44 lesion
samples contained OTUs in clade I, while this clade was
not present in saliva or throat samples (Figure 4, panel
inset). Manual inspection of the alignment file indicated
that OTUs within clade I differed in only short homo-
polymer sequences, 2–6 bp in length. Clades II and III
were less common and abundant (Figure 4, panel inset).
OTUs in clade II grouped with Streptococcus dentisani, a
recently described Streptococcus species [24]. Clade III
OTUs could not be identified to the species level, as
some species in the mitis group are indistinguishable inFigure 3 Comparison of bacterial community structure in
benign vocal fold lesions and throat and saliva samples from
the HMP. PCoA based on Theta Yue Clayton distances illustrating
the clustering of most lesion samples, regardless of lesion diagnosis
with the inclusion of 15 randomly selected throat and saliva HMP
samples. Lesion samples are shown as circles, cysts as orange circles,
nodules as yellow circles, polyps as red circles, and Reinke’s edema
as blue circles. HMP samples are shown as squares, saliva as green
squares, and throat as purple squares.this region of the 16S rRNA gene [23]. OTUs that
grouped outside these clades were also present, but at
very low abundance (data not shown).
Discussion
Maintenance of vocal fold function is essential for hu-
man health, where the consequences of impaired voice
production hold profound implications for individual
health and wellness, social and occupational function,
and societal productivity [3,4]. Benign vocal fold lesions
are one of the most common diagnoses when problems
with voice arise, but a full pathophysiologic understand-
ing of how and why these lesions form is still lacking.
We sought to describe the bacterial communities in a
large set of vocal fold biopsies that included cysts, nod-
ules, polyps, and Reinke’s edema. Surprisingly, the ma-
jority of our samples, 31 out of 44, had highly similar
bacterial communities dominated by S. pseudopneumo-
niae, regardless of lesion type, or any other documented
patient characteristic. To date, only one other study has
looked at whole bacterial communities in the larynx,
comparing LSCC to nearby “healthy” tissue, and a con-
trol group of patients with polyps [19]. Broad differences
are apparent between their control polyp patients and
ours, from the phyla level to the genus level, where
we found considerably more Streptococcus (71% vs.
56%), but less of all other genera they deemed dominant,
including Fusobacterium (0.6% vs. 8%), Prevotella (5%
vs. 7%), Neisseria (2% vs. 5%), and Gemella (0.5% vs. 2%).
It is widely accepted that even minor differences in sample
preparation can lead to discrepancies in community com-
position, and the differences found between our polyp
samples and those in Gong et al. could be due to any one
of these factors, including the use of different primer pairs
or DNA extraction protocols, and modifications to PCR
protocols [19,25-32].
The presence of Streptococcus is well noted in healthy
oral and respiratory sites [33-35]. However, due to the
high similarity of the 16S gene in many Streptococcus
species, finer resolution based on non-full length se-
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Figure 4 Phylogenetic relationship and abundance of the top 100 unique Streptococcus OTUs. The top 100 unique Streptococcus OTUs
along with 21 reference Streptococcus sequences were phylogenetically analyzed. Three major clades were found. Sequences from clade I
dominated the lesion samples while being completely absent from HMP samples. Panel inset represents the mean relative abundance of all
Streptococcus OTUs in cysts, nodules, polyps, Reinke’s edema, saliva, and throat, in addition to the portion represented by clades I, II, and III. Error
bars represent standard error.
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them were either S. pseudopneumoniae or S. pneumoniae.
These two Streptococcus species vary by a single base pair
in the region sequenced here, and a manual check of the
alignment showed that all sequences in clade I contained
a cytosine at that position, like S. pseudopneumoniae,
and no OTU out of the top 100 could be identified as
S. pneumoniae. Dominance by S. pseudopneumoniae in
the majority of our samples may be playing a role in dis-
ease progression. This recently described member of the
mitis group has many genes associated with host cell
interaction, including some of which are thought to be
virulence factors [36,37]. S. pseudopneumoniae, previously
thought to be atypical S. pneumoniae, has been isolated
from patients with a number of respiratory diseases in-
cluding chronic obstructive pulmonary disease (COPD),
cystic fibrosis, pneumonia, bronchitis, and chronic sinus-
itis [38-40]. However, its status as a pathogen, or mutual-
ist, is still not clear. All 20 human subjects in a tonsillar
crypt study were found to have S. pseudopneumoniae,
regardless of tonsil health status [41].
Helicobacter pylori is perhaps one of the most preva-
lent “infections” in the world, estimated to colonize the
stomach of over 50% of the world’s human population
[42]. Work in the last few decades has shown a direct re-
lation between H. pylori and stomach cancer [42], and
more recently, correlations have been made with other
aerodigestive tract diseases, such as otitis media with ef-
fusion [43] and oral aphthous ulcers [44]. H. pylori has
also been associated with LSCC [45-47], though there is
debate about whether it is associated with benign vocal
fold lesions [48] or not [47,49]. Only a few of the sam-
ples presented here contained Helicobacter and at very
low abundances. Many studies seeking to tie vocal fold
lesions to H. pylori infections have looked for the spe-
cific presence of the bacterium in the larynx [47], but
not necessarily at its abundance. It could be that H. pylori
is common in vocal folds, but at a low enough abundance
that it was mostly missed in our patient population and
with our sampling technique, even in those with previ-
ously diagnosed infections.
One limitation in our study design was the inability
to compare these lesions to the microbial community
that may be found in biopsied healthy human vocal folds.
The lamina propria of the vocal folds is very thin, only
3 mm thick, and the possibility of creating vocal scar andimpairing voice production is present with every surgical
procedure including biopsy. As such, it is considered un-
ethical to biopsy vocal folds of healthy human subjects. As
a proxy, we included in our analyses 15 randomly selected
saliva and throat samples on the basis that many of the
habitats above the stomach have similar microbial com-
munities due to the buffering nature of saliva, regular nu-
trient availability in the form of mucin, and a common
epithelial lining (non-keratinized, stratified, squamous epi-
thelium) [33]. Of the 15–18 body sites sampled by the
HMP, non-tooth oral sites, including saliva and throat,
were deemed to be highly similar [50]. Samples from these
body sites might have the most in common with our sam-
ples, considering that they all face similar environmental
exposures such as inhaled air, ingested substances (food
and beverage), and constant contact via saliva and a con-
tinuous mucus layer. Indeed, 13 of our 44 samples were
highly similar to these throat and saliva samples. However,
the majority harbored a distinct community, one domi-
nated by S. pseudopneumoniae, as described above. Inter-
estingly, of the 13 samples more similar to saliva and
throat, 12 of them contained Pseudomonas, a genus found
in only 1 throat sample. However, many of the common
and dominant genera found in the saliva and throat sam-
ples were also found in these 13 samples, including Actino-
myces, Prevotella, Fusobacterium, Leptotrichia, Neisseria,
Haemophilus, Gemella, Granulicatella, Oribacterium, Veil-
lonella, unclassified Prevotellaceae, and unclassified Lach-
nospiraceae [33]. Pseudomonas has been associated with
diseases of the lower respiratory system including bron-
chiolitis obliterans syndrome [51] and cystic fibrosis [52]
and could be playing a role in benign vocal fold lesion
etiology.
Conclusions
Benign vocal fold lesions are usually diagnosed based on
phenotypic differences present upon videostroboscopic
examination. While histological and gene expression differ-
ences have been noted, the data presented here adds to the
idea that despite phenotypic differences, benign vocal fold
lesions share many similarities, including highly similar
bacterial communities that are distinct from healthy throat
and saliva samples [8,9]. The possibility remains that these
shifts in the bacterial community could inhibit wound heal-
ing, or that the presence of inflammation creates a niche
for a community dominated by S. pseudopneumoniae.
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Subjects and collection of benign lesions
Benign vocal fold lesions were collected at University of
Wisconsin-Madison, USA, and the University of Hamburg,
Germany. Laryngeal microsurgical techniques were used to
remove lesions. For each lesion, the clinical diagnosis was
made based on initial videostroboscopic exam and con-
firmed under direct visualization by the surgeon at the time
of surgical removal. Samples were immediately placed in
RNAlater (Ambion Inc., Austin, Texas) and stored at −80°C
until use. The University of Wisconsin Madison Health
Sciences IRB and the University of Hamburg Ethics Com-
mittee approved the protocol for attainment of all tissue
samples. All subjects provided written consent to partici-
pate in this study. Meta data for each sample is detailed in
Additional file 1: Table S1.
DNA extraction and PCR for 454 pyrosequencing
DNA was extracted from tissue with the EpiCenter
MasterPure Complete DNA and RNA Purification Kit
(Illumina, Madison, WI) with modifications to the manu-
facturer’s protocol. Samples were gently thawed at room
temperature and briefly centrifuged to collect tissue. RNA-
later was removed by pipetting and 300 μl of tissue and
cell lysis solution was added to the tube with the tissue.
Lysis solution and tissue were then transferred to a sterile
screw top tube containing 150–200 mg of 400 μM silica
beads. Proteinase K, 100 μg, was added; the tubes were
vortexed and incubated at 55°C for 1 h, with vortexing
every 15 min. Bead tubes were then shaken in a horizontal
adapter on the vortex for 10 min. Rnase A, 5 μg, was
added; the tubes were vortexed and incubated at 37°C for
30 min. The remainder of the manufacturer’s protocol was
followed as written. DNA was resuspended in TE buffer
and stored at 4°C until use.
PCRs were performed in triplicates containing 50–100
ng of template DNA, 0.2 μl AccuPrime Taq DNA Poly-
merase (Life Technologies, Grand Island, NY), 2.5 μl
Buffer II, 400 nM both forward and reverse primers, and
water to 25 μl total. Thermocycling conditions were as
follows: 95°C 2 min, followed by 30 cycles of 95°C 20 s,
56°C 30 s, 72°C 1 min, and a final extension of 72°C
8 min. The primers included 357 F and 926R, as sug-
gested by the HMP [53], where 357 F contained the B
adapter for 454 pyrosequencing, and 926R contained both
the A adapter and a 10-base pair multiplex identifier.
Triplicate PCRs were pooled and cleaned using Purelink
PCR purification kit (Invitrogen, Grand Island, NY) as per
manufacturer’s directions for removal of primer dimers
and short PCR products <300 bp. Cleaned products were
eluted in 30 μl of elution buffer. Samples were then gel ex-
tracted from a low-melt agarose gel using Zymoclean Gel
DNA Recovery Kit (Zymo Research, Irvine, CA) by visual-
izing on a blue light transilluminator (Clare ChemicalResearch, Dolores, CO). Cleaned PCR products were
quantified using a Qubit fluorometer (Invitrogen, Grand
Island, NY). Products were diluted and pooled at equal
concentrations for 454 pyrosequencing.
454 pyrosequencing, data analysis, and statistics
454 pyrosequencing was conducted on a Roche GS Junior
(Roche, Indianapolis, IN) using titanium chemistry and
long read modifications found in Hanshew et al. [26].
Samples were sequenced across three picotiter plates. Raw
data were processed using mothur (v. 1.33.1) [54], with
most of the defaults put forth in the Schloss 454 SOP
(http://www.mothur.org/wiki/Schloss_SOP; accessed Jan
27, 2014) [55], but with minflows = 350 and maxflows =
720 [56]. Sequences were aligned to a Silva-derived refer-
ence data base (v. 102 as implemented for mothur) [57].
Chimeras were detected using UCHIME and removed
[58]. Sequences were assigned to taxonomic groups using
the Ribosomal Database Project (RDP)-derived reference
database [59]. All eukaryotic and unclassifiable reads were
removed after classify.seqs. Sequences were assigned to
OTUs at 97% sequence identity, used to construct a dis-
tance matrix using theta Yue and Clayton values, and ana-
lyzed with PCoA plots in Prism. Good’s coverage, Chao,
inverse Simpson, and Shannon were calculated in mothur.
One-way ANOVA with TukeyHSD p value correction for
pairwise comparison was used to assess differences in
Chao, inverse Simpson, and Shannon. In addition to lesion
diagnosis, bacterial communities were also compared based
on age, gender, date of surgery, and geographic location.
The data sets supporting the results of this article are avail-
able in the NCBI sequence read archive, SRP047304.
Thirty HMP samples, including 15 haphazardly se-
lected saliva and 15 throat (oropharynx) samples, were
included in further analyses as proxies for “healthy”
(Additional file 1: Table S1). As described above, Good’s
coverage, Chao, inverse Simpson, and Shannon diversity
indexes were calculated along with theta Yue and Clay-
ton values for PCoA at 97% sequence identity [53,60].
Similar to Jensen et al. and Scholz et al., the 100 most
abundant unique OTUs identified as Streptococcus were
chosen for phylogenetic analysis [41,61]. Sequences
were aligned in MEGA6 using ClustalW and trimmed at
the ends [62]. A phylogenetic tree was created in MEGA6
using maximum likelihood with 500 bootstraps. Sequences
were searched in the Ribosomal Database Project, and
matching type strain sequences were included in the
phylogenetic analysis, including S. cristatus (AY188347),
S. infantis (AY485603), S. lactarius (GU045364), S. mitis
(AF003929), S. oralis (AY485602), S. parasanguinis (AF003933),
S. peroris (AB008314), S. pneumoniae (AF003930), S. pseudop-
neumoniae (AY612844, AY485599, EU156784, and EU156788),
S. salivarius (AY188352), S. sanguinis (AF003928), S.
sinensis (AF432856), S. vestibularis (AY188353) [59,63].
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S. rubneri (JX861485), and S. tigurinus (JN004270) were in-
cluded due to the high match to some OTUs. S. pyogenes
(AB002521) was included as an outgroup.
Additional file
Additional file 1: Table S1. Meta data for each lesion sample along
with a list of the haphazardly chosen HMP samples.
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